![]() Therapeutic class and subclass were assigned to MEPS prescribed medicines using Multum Lexicon variables from Cerner Multum, Inc. Out of pocket includes expenses paid by the user or other family member. Expense estimates for 2002 were adjusted to 2012 dollars based on the GDP Price Index ( ). Expenses include the total direct payments from all sources to pharmacies for prescriptions reported by respondents in the MEPS-HC. ![]() Refills as well as original prescriptions are included in expense and utilization estimates. Utilization was defined as purchasing or obtaining opioids in the year of interest. The estimates in this Statistical Brief are based upon data from the MEPS Prescribed Medicines Data Files 2002–2012 (HC-67A, HC-77A, HC-85A, HC-94A, HC-102A, HC-110A, HC-118A, HC-126A, HC-135A, HC-144A, and HC-152A). In 2002, the average annual out of pocket expense (in 2012 dollars) for prescribed outpatient opioids for those with an expense was $85 and decreased to $45 in 2012, a decrease of 47.1 percent (figure 6). When comparing 2002 with 2012, total out of pocket expense (in 2012 dollars) for outpatient prescribed opioids decreased from $2.3 billion to $1.6 billion, a 30.4 percentage decrease (figure 5). The mean annual expense (in 2012 dollars) per person for outpatient prescribed opioids for those with an expense increased when comparing 2002 with 2012, rising from $149 to $246, approximately a 65 percentage increase (figure 4). civilian noninstitutionalized population, total expenses (in 2012 dollars) for outpatient prescription opioids increased approximately 120 percent, rising from $4.1 billion to $9.0 billion, when comparing 2002 with 2012 (figure 3). When comparing 20, MEPS estimates showed growth in the total number of outpatient prescription purchases of opioids, rising from 85.9 million purchases to 143.9 million purchases, an increase of 67.5 percent (figure 2).Īmong the U.S. civilian noninstitutionalized population, and in 2012 the total number of people purchasing one or more prescribed outpatient opioid increased to 36.7 million (figure 1). In 2002, MEPS estimates show that 27.2 million people purchased one or more outpatient prescribed opioids in the U.S. Expense estimates for 2002 were inflated to 2012 dollars based on the GDP Price Index ( ).Īll differences between estimates discussed in the text are statistically significant at the 0.05 level. Prescription medicines administered in an inpatient setting or in a clinic or physician's office are excluded. Only prescriptions purchased or obtained in an outpatient setting are included in these estimates. The Brief examines trends in the number of persons purchasing at least one outpatient prescription opioid, and total expenses and total number of prescriptions, as well as average annual cost per person and total and average out of pocket costs. civilian noninstitutionalized population from 2002 through 2012. This Statistical Brief presents estimates of use and expenses for outpatient prescribed opioids for the U.S. When comparing 2002 with 2012, the mean annual real expense (in 2012 dollars) for outpatient prescribed opioids for those with an expense increased from $149 to $246.civilian noninstitutionalized population when comparing 2002 with 2012. The total number of people in the U.S civilian noninstitutionalized population purchasing one or more outpatient prescribed opioid increased from 27.2 million to 36.7 million among the U.S.civilian noninstitutionalized population. When comparing 2002 with 2012, total prescription opioid purchases increased from 85.9 million to 143.9 million among the U.S.civilian noninstitutionalized population, total expenses (in 2012 dollars) for outpatient prescription opioids more than doubled, increasing from $4.1 billion to $9.0 billion, when comparing 2002 with 2012. Civilian Noninstitutionalized Population, 2002-2012 Trends in Prescribed Outpatient Opioid Use and Expenses in the U.S.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |